Morgan Lewis represented Idera Pharmaceuticals Inc. in the transaction. Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) entered into an agreement with a fund affiliated with institutional investors providing…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now